Literature DB >> 35308147

Telehealth Technologies and Their Benefits to People With Diabetes.

Chinenye O Usoh1, Kristine Kilen2, Carolyn Keyes1, Crystal Paige Johnson1, Joseph A Aloi1.   

Abstract

This article reviews the current diabetes technology landscape and how recent advancements are being used to help overcome barriers in the management of diabetes. The authors offer case examples of how digital tools and platforms can facilitate diabetes care via telehealth and remote patient monitoring for individuals in special populations. They also provide tips to ensure success in implementing diabetes technology to provide the best possible care for people with diabetes in outpatient settings.
© 2022 by the American Diabetes Association.

Entities:  

Year:  2022        PMID： 35308147      PMCID： PMC8914588          DOI： 10.2337/dsi21-0017

Source DB:  PubMed          Journal:  Diabetes Spectr        ISSN： 1040-9165


  25 in total

1.  Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes.

Authors:  Sue A Brown; Boris P Kovatchev; Dan Raghinaru; John W Lum; Bruce A Buckingham; Yogish C Kudva; Lori M Laffel; Carol J Levy; Jordan E Pinsker; R Paul Wadwa; Eyal Dassau; Francis J Doyle; Stacey M Anderson; Mei Mei Church; Vikash Dadlani; Laya Ekhlaspour; Gregory P Forlenza; Elvira Isganaitis; David W Lam; Craig Kollman; Roy W Beck
Journal:  N Engl J Med       Date:  2019-10-16       Impact factor: 91.245

2.  A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

Authors:  J Hans DeVries; Frank J Snoek; Piet J Kostense; Nathalie Masurel; Robert J Heine
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

3.  "I'm Not Feeling Like I'm Part of the Conversation" Patients' Perspectives on Communicating in Clinical Video Telehealth Visits.

Authors:  Howard S Gordon; Pooja Solanki; Barbara G Bokhour; Ravi K Gopal
Journal:  J Gen Intern Med       Date:  2020-02-03       Impact factor: 5.128

Review 4.  Going beyond HbA1c to understand the benefits of advanced diabetes therapies.

Authors:  Robert A Vigersky
Journal:  J Diabetes       Date:  2018-10-08       Impact factor: 4.006

5.  Safety and usability evaluation of a web-based insulin self-titration system for patients with type 2 diabetes mellitus.

Authors:  Airin C R Simon; Frits Holleman; Wouter T Gude; Joost B L Hoekstra; Linda W Peute; Monique W M Jaspers; Niels Peek
Journal:  Artif Intell Med       Date:  2013-06-02       Impact factor: 5.326

6.  Real-World Efficacy of the Hybrid Closed-Loop System.

Authors:  Chinenye O Usoh; Crystal Paige Johnson; Jaime L Speiser; Richa Bundy; Ajay Dharod; Joseph A Aloi
Journal:  J Diabetes Sci Technol       Date:  2021-01-11

7.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.

Authors:  Satish K Garg; Stuart A Weinzimer; William V Tamborlane; Bruce A Buckingham; Bruce W Bode; Timothy S Bailey; Ronald L Brazg; Jacob Ilany; Robert H Slover; Stacey M Anderson; Richard M Bergenstal; Benyamin Grosman; Anirban Roy; Toni L Cordero; John Shin; Scott W Lee; Francine R Kaufman
Journal:  Diabetes Technol Ther       Date:  2017-01-30       Impact factor: 6.118

Review 8.  Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications.

Authors:  Giacomo Cappon; Martina Vettoretti; Giovanni Sparacino; Andrea Facchinetti
Journal:  Diabetes Metab J       Date:  2019-08       Impact factor: 5.376

9.  Efficacy of a Smart Insulin Pen Cap for the Management of Patients with Uncontrolled Type 2 Diabetes: A Randomized Cross-Over Trial.

Authors:  Rodolfo J Galindo; Clementina Ramos; Saumeth Cardona; Priyathama Vellanki; Georgia M Davis; Omolade Oladejo; Bonnie Albury; Neil Dhruv; Limin Peng; Guillermo E Umpierrez
Journal:  J Diabetes Sci Technol       Date:  2021-07-22

10.  Increased Time in Range and Fewer Missed Bolus Injections After Introduction of a Smart Connected Insulin Pen.

Authors:  Peter Adolfsson; Niels Væver Hartvig; Anne Kaas; Jonas Bech Møller; Jarl Hellman
Journal:  Diabetes Technol Ther       Date:  2020-03-11       Impact factor: 6.118
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.